SUPPLEMENTAL FIGURE LEGENDS
Figure S1: Profiling mammalian RNA decay pathways (related to Figure 1) . A Western blots showing expression and biotinylation of endogenously tagged 3xFLAG-AviTag SKIV2L, XRN1 and MTR4. B
Scree plot for the PCA in Figure 1C . C Western blot analysis of a co-immunoprecipitation using anti-HA to capture 2xHA-FKBP12-tagged DIS3L, and probing inputs and eluates with anti-FLAG (to detect 3xFLAG-Avi-SKIV2L) and anti-MTR4. D tSNE representation of mRNAs based on relative binding to MTR4, SKIV2L and XRN1, and highlighting functional classes of mRNAs. E RT-qPCR analysis of Skiv2l fl/fl mRNA expression levels in clones 5F and 9E (Table S1) after 0.1 µM 4OHT treatment for 0, 2, 4 and 6 days. Error bars denote standard deviation of two technical replicates. Values are normalized to TBP expression and then to untreated samples (day 0). F Boxplot for the 7240 mRNAs analyzed in Figure 1I , grouped by differential expression after four days of Skiv2l knockout, and showing the extent to which they bind SKIV2L in WT cells (relative binding based on CRAC, defined in Figure 1E ). Box widths are proportional to the number of contained transcripts. p < 10 -15 for upregulated versus downregulated transcripts (Mann-Whitney U test). G Log2-fold changes in transcriptome-wide mRNA half-lives for Skiv2l fl/fl cells following 0.1 µM 4OHT treatment for 4 or 0 days. Half-lives were calculated by fitting an exponential decay model to RNA-seq counts from an actinomycin D-mediated transcription shut-off time course. The x-axis shows the extent of SKIV2L binding as a fraction of total SKIV2L+XRN1 binding (i.e. SKIV2L CRAC divided by SKIV2L+XRN1 CRAC, using "relative binding" values defined in Figure 1E ).
High confidence SKIV2L targets are indicated in red, and are defined as mRNAs with an increased halflife after Skiv2l knockout (y-axis > 0.1), high SKIV2L binding (x-axis > 0.5) and significant RNA increase after 4 days of Skiv2l knockout ( Figure 1I ). The half-lives of the 200 most highly SKIV2L-bound mRNAs (right of green dashed line) were compared to those of all other mRNAs using a Student's t-test. H RNA levels for high confidence SKIV2L targets (red circles in G) for wild-type, tagged (Skiv2l 3xFLAG-Avi/3xFLAG-Avi , Mtr4 3xFLAG-Avi/3xFLAG-Avi and Xrn1 3xFLAG-Avi/3xFLAG-Avi ) and Skiv2l fl/fl (+ 4 days 4OHT) cells. Each point refers to a separate cell line. See also Tables S1-S3. Figure 4) . A Scree plot for the PCA in Figure   4C . B Left, schematic of CRISPR-Cas9-induced Aven knockout and RNA-seq tracks in the parental Figure   4F , including all transcripts (not only those differentially bound or expressed). AVEN CRAC counts in WT are shown (y-axis) for transcripts grouped by changes in SKIV2L binding (B; p < 10 -15 ) or RNA abundance (C; p = 0.002) in Aven -/versus WT (x-axis). P-values calculated using a Mann-Whitney U test to compare up-and down-regulated transcripts. See also Tables S1 and S3.
Figure S4: AVEN and SKIV2L counteract ribosome stalling (related to Figures 4 and 5). A Changes
in mRNA monosome and disome densities in Aven -/versus WT. Transcripts are colored by AVEN binding in WT cells (calculated as in Figure 4F ; high, n = 777; low, n = 5471), and a linear best fit line plotted for each group (shaded area = 95 % confidence interval). B Western blot analysis of SKIV2L levels in Aven -/-Skiv2l 3xFLAG-Avi/3xFLAG-Avi Skiv2l fl/fl cells after treatment with 0.1 µM 4OHT for 0, 2 or 4 days to induce Skiv2l knockout. C Log2 fold change in the half-lives of AVEN targets, which are defined as mRNAs that accumulate upon combined knockout of Aven and Skiv2l (p < 0.01; Figure 5D ) and that have increased SKIV2L binding in Aven -/cells (differential binding > 0.5, Figure 5D ). Three comparisons are shown (left Figure 7) . A GC content and B predicted free energy for the "non-coding" 1 kb genomic windows analyzed in Figure 7C . Windows are split into four categories based on differential SKIV2L CRAC counts in Aven -/versus WT cells (defined in Figure   7C ). C PhyloCSF scores for predicted small ORFs within these windows. Windows are classified based upon whether SKIV2L CRAC and monosome profiling counts increase in Aven -/versus WT cells, or not. Tables S6 and S7. 
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